Smolen JS - Search Results

1

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis.

Winthrop KL, Harigai M, Genovese MC, Lindsey S, Takeuchi T, Fleischmann R, Bradley JD, Byers NL, Hyslop DL, Issa M, Nishikawa A, Rooney TP, Witt S, Dickson CL, Smolen JS, Dougados M. Winthrop KL, et al. Among authors: smolen js. Ann Rheum Dis. 2020 Oct;79(10):1290-1297. doi: 10.1136/annrheumdis-2019-216852. Epub 2020 Aug 11. Ann Rheum Dis. 2020. PMID: 32788396 Free article.

2

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Machold KP, Neumann K, Smolen JS. Machold KP, et al. Among authors: smolen js. Ann Rheum Dis. 1992 Sep;51(9):1039-43. doi: 10.1136/ard.51.9.1039. Ann Rheum Dis. 1992. PMID: 1417133 Free PMC article. Clinical Trial.

3

Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Pietschmann P, Machold KP, Wolosczuk W, Smolen JS. Pietschmann P, et al. Among authors: smolen js. Ann Rheum Dis. 1989 Aug;48(8):654-7. doi: 10.1136/ard.48.8.654. Ann Rheum Dis. 1989. PMID: 2789500 Free PMC article.

4

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, Smolen JS, Khaltaev N, Muirden KD. Boers M, et al. Among authors: smolen js. J Rheumatol Suppl. 1994 Sep;41:86-9. J Rheumatol Suppl. 1994. PMID: 7799394

5

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R. Smolen JS, et al. Lancet. 1999 Jan 23;353(9149):259-66. doi: 10.1016/s0140-6736(98)09403-3. Lancet. 1999. PMID: 9929017 Clinical Trial.

6

Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis.

Köller M, Aringer M, Kiener H, Erlacher L, Machold K, Eberl G, Studnicka-Benke A, Graninger W, Smolen J. Köller M, et al. Ann Rheum Dis. 1999 Nov;58(11):709-12. doi: 10.1136/ard.58.11.709. Ann Rheum Dis. 1999. PMID: 10531076 Free PMC article.

7

Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis.

Smolen JS. Smolen JS. Scand J Rheumatol Suppl. 1999;112:15-21. doi: 10.1080/030097499750042245-1. Scand J Rheumatol Suppl. 1999. PMID: 10668523 Clinical Trial.

8

Efficacy and safety of leflunomide in active rheumatoid arthritis.

Smolen JS, Emery P. Smolen JS, et al. Rheumatology (Oxford). 2000 Jun;39 Suppl 1:48-56. doi: 10.1093/oxfordjournals.rheumatology.a031495. Rheumatology (Oxford). 2000. PMID: 11001380

9

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I; European Leflunomide Study Group. Scott DL, et al. Among authors: smolen js. Ann Rheum Dis. 2001 Oct;60(10):913-23. doi: 10.1136/ard.60.10.913. Ann Rheum Dis. 2001. PMID: 11557646 Free PMC article. Clinical Trial.

10

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Emery P, et al. Among authors: smolen js. Ann Rheum Dis. 2002 Apr;61(4):290-7. doi: 10.1136/ard.61.4.290. Ann Rheum Dis. 2002. PMID: 11874828 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

822 results

Search Page